4th Microbiome Movement - Drug Development Summit

Temas de la conferencia
Pursuing Disease Causation to Foster the Creation of Targeted Microbiome-Based Therapeutics, Biomarkers & Diagnostics

The study of the human microbiome remains one of the most exciting frontiers in modern medicine, that, if targeted correctly, has the potential to benefit millions of patients suffering from numerous diseases. However, the potential for effective disease treatment through the microbiome is matched by the unique challenges in developing them.

Organizador profesional (PCO)
Microbiome Movement

Observaciones
Speakers: Bernat Olle, CEO, Vedanta Biosciences, Dan Knights, CEO, CoreBiome, Esi Lamouse-Smith, Director, Janssen Pharmaceuticals, Liz Shepherd, Co-Founder, Novome Biotechnologies, Matthew Henn, EVP Microbiome R&D, Seres Therapeutics, Mike Romanos,

Tickets: https://go.evvnt.com/354252-2?pid=4832

Mr. Jenna Warren